Literature DB >> 31108160

Rett syndrome before regression: A time window of overlooked opportunities for diagnosis and intervention.

Livia Cosentino1, Daniele Vigli1, Francesca Franchi1, Giovanni Laviola1, Bianca De Filippis2.   

Abstract

Rett syndrome (RTT) is a rare neurological disorder primarily affecting females, causing severe cognitive, social, motor and physiological impairments for which no cure currently exists. RTT clinical diagnosis is based on the peculiar progression of the disease, since patients show an apparently normal initial development with a subsequent sudden regression at around 2 years of age. Accumulating evidences are rising doubts regarding the absence of early impairments, hence questioning the concept of regression. We reviewed the published literature addressing the pre-symptomatic stage of the disease in both patients and animal models with a particular focus on behavioral, physiological and brain abnormalities. The emerging picture delineates subtle, but reliable impairments that precede the onset of overt symptoms whose bases are likely set up already during embryogenesis. Some of the outlined alterations appear transient, suggesting compensatory mechanisms to occur in the course of development. There is urgent need for more systematic developmental analyses able to detect early pathological markers to be used as diagnostic tools and precocious targets of time-specific interventions.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Early alterations; MeCP2; Ontogeny; Postnatal development; RTT

Year:  2019        PMID: 31108160     DOI: 10.1016/j.neubiorev.2019.05.013

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  9 in total

Review 1.  Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges.

Authors:  Silvia Vidal; Clara Xiol; Ainhoa Pascual-Alonso; M O'Callaghan; Mercè Pineda; Judith Armstrong
Journal:  Int J Mol Sci       Date:  2019-08-12       Impact factor: 5.923

Review 2.  Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic.

Authors:  Shilpa D Kadam; Brennan J Sullivan; Archita Goyal; Mary E Blue; Constance Smith-Hicks
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

3.  Unraveling Molecular Pathways Altered in MeCP2-Related Syndromes, in the Search for New Potential Avenues for Therapy.

Authors:  Alba-Aina Castells; Rafel Balada; Alba Tristán-Noguero; Mar O'Callaghan; Elisenda Cortès-Saladelafont; Ainhoa Pascual-Alonso; Àngels Garcia-Cazorla; Judith Armstrong; Soledad Alcántara
Journal:  Biomedicines       Date:  2021-02-03

4.  The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes.

Authors:  Linda Scaramuzza; Giuseppina De Rocco; Genni Desiato; Clementina Cobolli Gigli; Martina Chiacchiaretta; Filippo Mirabella; Davide Pozzi; Marco De Simone; Paola Conforti; Massimiliano Pagani; Fabio Benfenati; Fabrizia Cesca; Francesco Bedogni; Nicoletta Landsberger
Journal:  EMBO Mol Med       Date:  2021-03-05       Impact factor: 12.137

5.  JNK signaling provides a novel therapeutic target for Rett syndrome.

Authors:  Clara Alice Musi; Anna Maria Castaldo; Anna Elisa Valsecchi; Sara Cimini; Noemi Morello; Riccardo Pizzo; Alessandra Renieri; Ilaria Meloni; Maurizio Bonati; Maurizio Giustetto; Tiziana Borsello
Journal:  BMC Biol       Date:  2021-12-16       Impact factor: 7.431

Review 6.  Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review.

Authors:  Giorgia Tascini; Giovanni Battista Dell'Isola; Elisabetta Mencaroni; Giuseppe Di Cara; Pasquale Striano; Alberto Verrotti
Journal:  Front Neurol       Date:  2022-03-01       Impact factor: 4.003

7.  Systematic analysis of goal-related movement sequences during maternal behaviour in a female mouse model for Rett syndrome.

Authors:  Parker K Stevenson; Devin M Casenhiser; Billy Y B Lau; Keerthi Krishnan
Journal:  Eur J Neurosci       Date:  2021-06-22       Impact factor: 3.698

8.  Comprehensive Analysis of GABAA-A1R Developmental Alterations in Rett Syndrome: Setting the Focus for Therapeutic Targets in the Time Frame of the Disease.

Authors:  Alfonso Oyarzabal; Clara Xiol; Alba Aina Castells; Cristina Grau; Mar O'Callaghan; Guerau Fernández; Soledad Alcántara; Mercè Pineda; Judith Armstrong; Xavier Altafaj; Angels García-Cazorla
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

9.  MeCP2 deficiency exacerbates the neuroinflammatory setting and autoreactive response during an autoimmune challenge.

Authors:  M I Zalosnik; M C Fabio; M L Bertoldi; C N Castañares; A L Degano
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.